<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376126</url>
  </required_header>
  <id_info>
    <org_study_id>MI-ILP</org_study_id>
    <nct_id>NCT03376126</nct_id>
  </id_info>
  <brief_title>Minimally-Invasive Isolated Limb Perfusion</brief_title>
  <acronym>MI-ILP</acronym>
  <official_title>Minimally-Invasive Isolated Limb Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to analyse feasibility of a minimally-invasive isolated limb perfusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Isolated limb perfusion (ILP) and isolated limb infusion (ILI) are treatment options for
      patients with in-transit metastases of melanoma and locally advanced extremity sarcomas.
      There are several advantages for each method, but if the well-established effects of ILP
      could be combined to the minimally invasive approach of ILI, the results could be maximized
      and adverse events, related to open approach, minimized.

      A new method for vascular approach (MI-ILP) will be evaluated in a phase I feasibility study.
      Percutaneous vascular access of the ipsilateral side will be performed by ultrasound guided
      technique and connected to an extracorporeal oxygenation system. Perfusion will be conducted
      in the same way as for open ILP. Outcomes, technical details and complications will be
      recorded prospectively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Conversion to open surgery</measure>
    <time_frame>1 day</time_frame>
    <description>Number of minimal-invasive procedure that will be converted to open surgery (per cent)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical response rate according to WHO criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complications according to Clavien-Dindo</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Isolated Limb Perfusion</condition>
  <arm_group>
    <arm_group_label>MI-ILP</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Minimal-invasive isolated limb perfusion</intervention_name>
    <description>Minimal-invasive isolated limb perfusion</description>
    <arm_group_label>MI-ILP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for isolated limb perfusion.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient scheduled for treatment with isolated hyperthermic perfusion

          2. Age over 18 years.

          3. Signed informed consent

        Exclusion Criteria:

          1. Re-perfusion

          2. Lymph node metastases

          3. Severe atherosclerosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Roger Olofsson Bagge, MD, PhD</last_name>
    <phone>+46 31 3420000</phone>
    <email>roger.olofsson.bagge@gu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger Olofsson Bagge, MD, PhD</last_name>
      <phone>+46 31 3428207</phone>
      <email>roger.olofsson@surgery.gu.se</email>
    </contact>
    <investigator>
      <last_name>Roger Olofsson Bagge, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Roger Olofsson Bagge</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>isolated limb perfusion</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

